Company
Maxwell Biosciences
Restore Immunity. Repair Tissues. Extend Healthspan.
Also known as Maxwell Biosciences, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2016
- Legal name
- Maxwell Biosciences, Inc
- maxwellbiosciences.com (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Founded in 2016, Maxwell is a preclinical stage biotechnology company targeting viruses, bacteria, fungi, and biofilm formations, including those that cause many currently untreatable infectious diseases.
Funding snapshot
- Total raised
- $20MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $20M2025-08-05
Funding rounds
- Round, 2025
- $20M2025-08-05, Company stated
- Round, 2023
- 2023-07-14
- Round, 2021
- $10.9M2021-10-04, SEC form D sold, 96 investors
Products
- Other
- MXB-22,510
Loading relationship preview